Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Neoplasms 38Breast Neoplasms 31Lung Neoplasms 25Colorectal Neoplasms 15Prostatic Neoplasms 13Pancreatic Neoplasms 11Ovarian Neoplasms 11Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Sarcoma 8Colonic Neoplasms 8Uterine Cervical Neoplasms 7Melanoma 7Glioma 7Esophageal Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplastic Cells, Circulating 5Multiple Myeloma 5Endometrial Neoplasms 5Brain Neoplasms 5Neoplasm, Residual 4Gastrointestinal Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Renal Cell 4Adenocarcinoma 4Thrombosis 3Skin Neoplasms 3

Interventions

Specimen Handling 9fludarabine 8Cyclophosphamide 7Biopsy 6ruxolitinib 5Whole-Body Irradiation 5Stem Cell Transplantation 5Azacitidine 5venetoclax 4Tacrolimus 4Injections 4Cytarabine 4Busulfan 4ivosidenib 3fludarabine phosphate 3Thiotepa 3Mycophenolic Acid 3Melphalan 3Cyclosporins 3CPX-351 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3luspatercept 2decitabine and cedazuridine drug combination 2X-Rays 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Liposomes 2Gemtuzumab 2Daunorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Myeloproliferative Disorders × Blood Specimen Collection × Clear all
NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Wake Forest University Health Sciences

Recruiting
35 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

NCT05839717 2024-12-17

CLOJAK

University Hospital, Bordeaux

Recruiting
120 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡